Orchestra BioMed Holdings (OBIO) Return on Sales (2022 - 2026)

Orchestra BioMed Holdings (OBIO) reported Return on Sales of 2.08% for Q1 2026, down 187.0% year-over-year from 2.39% in Q1 2025, and down 107519.7% on a QoQ basis from 0.0% in Q4 2025.

Orchestra BioMed Holdings (OBIO) has 5 years of Return on Sales data on file, last reported at 2.08% in Q1 2026.

  • Quarterly Return on Sales fell 187.0% year-over-year to 2.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (up 21.0% YoY) and the FY2025 annual result came in at 0.02%, up 22.0% from the prior year.
  • Return on Sales fell to 2.08% in Q1 2026 per OBIO's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q4 2025 and bottomed at 2.08% in Q1 2026.
  • The 5-year median for Return on Sales is 0.21% (2024), against an average of 0.32%.
  • The widest annual swing landed in 2025, when Return on Sales jumped 64 bps; it then tumbled 187 bps in 2026.
  • Tracing OBIO's Return on Sales over 5 years: stood at 0.09% in 2022, then tumbled by 387 bps to 0.43% in 2023, then sank by 47 bps to 0.64% in 2024, then soared by 100 bps to 0.0% in 2025, then slumped by 107520 bps to 2.08% in 2026.
  • Per Business Quant, the three latest OBIO Return on Sales figures stand at 2.08% (Q1 2026), 0.0% (Q4 2025), and 0.24% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 0.00%
7 Evaxion A 64.16 Bn 64.14 Bn - 0.00%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 0.00%
10 Orchestra BioMed Holdings 245.24 Mn 255.02 Mn 78,000.00 -2.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.08%
Dec 31, 2025 0.00%
Sep 30, 2025 -0.24%
Jun 30, 2025 -0.23%
Mar 31, 2025 -0.22%
Dec 31, 2024 -0.64%
Sep 30, 2024 -0.16%
Jun 30, 2024 -0.21%
Mar 31, 2024 -0.22%
Dec 31, 2023 -0.43%
Sep 30, 2023 -0.32%
Jun 30, 2023 -0.14%
Mar 31, 2023 -0.10%
Dec 31, 2022 -0.09%
Sep 30, 2022 -0.09%
Jun 30, 2022 -0.19%
Mar 31, 2022 -0.06%